Which ETFs hold Eli Lilly & Co (LLY)?
American drugmaker known for diabetes and weight-loss medicines such as Mounjaro.
45 Australian ETFs hold Eli Lilly & Co, a Health Care company from United States. IXJ has the biggest weighting at 11.62%. Across these funds, Australian ETF investors own about $2.1bn of Eli Lilly & Co.
The ETFs with the most Eli Lilly & Co
All 45 ETFs that hold Eli Lilly & Co, ranked by weight
Best-endeavours estimate. Built from each issuer's published holdings, which may be weeks or months old, may cover only part of a fund (some publish only their top 10) and are matched by company name. Figures may be incomplete or inaccurate. Check the issuer's website and PDS before relying on them. General information only.
Weights from each issuer's published holdings (September to November 2026). Some funds list only their largest holdings. General information only, not a recommendation to buy or sell Eli Lilly & Co.
Common questions
Which ETF has the most Eli Lilly & Co?
IXJ (iShares Global Healthcare ETF) has the highest weighting, with 11.62% of the fund in Eli Lilly & Co.
What is the cheapest ETF that holds Eli Lilly & Co?
Of the ETFs where Eli Lilly & Co is at least 1% of the fund, VTS has the lowest fee at 0.03% a year, with 1.39% in Eli Lilly & Co.
How much Eli Lilly & Co do I own with $10,000 in VGS?
About $102. VGS is the largest ETF that holds Eli Lilly & Co, and Eli Lilly & Co makes up 1.02% of it.
How many Australian ETFs hold Eli Lilly & Co?
45 ETFs listed on the ASX or TMX Australia hold Eli Lilly & Co, based on issuers' published holdings.